BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3906676)

  • 1. Single-dose cefotetan for urinary tract infection.
    Sanderson PJ
    Pharmatherapeutica; 1985; 4(5):332-4. PubMed ID: 3906676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study of cefotetan in complicated urinary tract infections].
    Suzuki T; Soma H; Tazawa H; Hamada W; Sugihara K; Fukushi M; Eba H
    Hinyokika Kiyo; 1987 Nov; 33(11):1917-20. PubMed ID: 3481955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of cefotetan in the treatment of complicated urinary tract infections: clinical experience in a selective and single study.
    Gesualdo L; Quarto M; Viggiani N; Germinario C; Barbuti S; Schena FP
    Drugs Exp Clin Res; 1989; 15(6-7):309-13. PubMed ID: 2591302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cefotetan: clinical trial in elderly persons using a single daily dose of 2 grams as the sole therapy].
    Gaillat J; Croize J; Bru JP; Stahl JP; Le Noc P; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):461-4. PubMed ID: 3534722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report on a comparative trial of cefotetan and cefoxitin in the treatment of urinary tract infections.
    Cox CE; Childs SJ; Wells WG; Mirelmant S; Lesky WC
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():227-32. PubMed ID: 6341350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotetan in complicated urinary tract infections--clinical experience.
    Hautmann R; Pranada F; Pusztai-Markos Z
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():223-6. PubMed ID: 6573321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriological and clinical evaluation of cefotetan in the treatment of severe infections in hospitalized patients.
    Romanelli G; Agabiti-Rosei E; Giustina A; Guarnera L; Muiesan ML; Pelizzari G; Turano A
    Drugs Exp Clin Res; 1988; 14(6):411-7. PubMed ID: 3215108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double-blind comparison of cefotetan and cefmetazole in complex urinary tract infections].
    Kamidono S; Ishigami J; Arakawa S; Umezu K; Ohmori H; Ishito N; Nihira H; Ishino T; Kurokawa K; Fujimura N
    Jpn J Antibiot; 1983 Jun; 36(6):1325-53. PubMed ID: 6361310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cefotetan vs ceftriaxone: clinical and bacteriological efficacy in complicated forms of urinary tract infection].
    D'Amato C; De Carli G; Leoni GC; Bordi E; Carvelli C; Colaiacomo M; Struglia C; Visco G
    Clin Ter; 1989 Mar; 128(5):347-50. PubMed ID: 2524322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of cefmetazole in urological infections].
    Mitsuya H; Naide Y; Ohtaguro K; Segawa A
    Hinyokika Kiyo; 1984 Jan; 30(1):87-95. PubMed ID: 6587764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose treatment of lower urinary tract infections with fosfomycin trometamol: preliminary experiences.
    Arione R; Fontana P
    Chemioterapia; 1987 Aug; 6(4):295-8. PubMed ID: 3308148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Our experience of treating urological infections with a single dose of gentamycin].
    Belovezhdov N; Angelova I; Stefanov G; Stoianova M; ChakÅ­rski I
    Vutr Boles; 1988; 27(2):101-3. PubMed ID: 3414092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience with cefotetan in the treatment of infections of children].
    Nagamatsu I; Okuno H; Takase A; Tachibana K
    Jpn J Antibiot; 1983 Jun; 36(6):1199-203. PubMed ID: 6581326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microbiological, kinetic and clinical study on a new cephamycin: cefotetan].
    Soranzo ML; Capra E; Eandi M; Angela GC; Musso E; Bendiscioli L; Salassa B; Braida M; Lollini P; Pizzo L; Cignolo G; Spezia C; Andreoni G; Bramato C; di Nola F
    Minerva Med; 1983 Jun; 74(27):1639-50. PubMed ID: 6343925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Richards DM
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotetan in the treatment of serious intra-abdominal sepsis: a controlled clinical trial.
    Scott SD; Karran SJ
    Int J Clin Pharmacol Res; 1987; 7(3):229-31. PubMed ID: 3298087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with cefmetazole in the urological field].
    Aga Y; Yano M; Ogura K
    Hinyokika Kiyo; 1983 Apr; 29(4):459-63. PubMed ID: 6587763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical application of cefotetan in pediatrics].
    Kobayashi Y; Haruta T; Okura K; Kuroki S
    Jpn J Antibiot; 1983 Jun; 36(6):1313-6. PubMed ID: 6581336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience in the treatment of complicated urinary tract infection with different doses of moxalactam (lamoxactam).
    Hautmann R; Pranada F; Ahlert G
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):209-12. PubMed ID: 6222995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of MT-141, a new cephamycin antibiotic, on acute urinary tract infections.
    Miyamoto S; Tamiya T; Takatsuka K; Kumamoto Y
    Drugs Exp Clin Res; 1985; 11(6):379-82. PubMed ID: 3939123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.